Articles published by Can-Fite BioPharma Ltd.
Can-Fite Updates: Namodenoson Increases Survival for the Most Severe Patients with Advanced Liver Cancer
December 28, 2022
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Can-Fite to Present its Phase IIb NASH Drug Candidate Namodenoson at Upcoming Conference
October 13, 2022
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Can Fite Announces First Patient Enrolled in Phase IIb NASH Clinical Trial with Namodenoson
January 31, 2022
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|